tiprankstipranks
Yield10 Bioscience (YTENQ)
OTHER OTC:YTENQ
US Market

Yield10 Bioscience (YTENQ) Income Statement

Compare
332 Followers

Yield10 Bioscience Income Statement

Last quarter (Q2 2024), Yield10 Bioscience's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Yield10 Bioscience's net income was $-3.24M. See Yield10 Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 60.00K$ -7.30M$ 6.82M$ 6.16M$ -4.04M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ -263.00K$ 220.00K$ 182.00K$ -203.00K
EBITDA
$ -14.16M$ -13.15M$ -11.47M$ -9.43M$ -13.01M
Operating Income
$ -14.42M$ -13.45M$ -11.69M$ -9.61M$ -8.60M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -14.46M$ -13.57M$ -11.03M$ -10.21M$ -12.96M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Yield10 Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis